Abstract
Breast cancer is the leading cause of cancer-related mortality among Hispanic women in the U.S., despite a lower incidence compared to non-Hispanic White women. Hispanic women often face unique socio-economic and cultural barriers that impact timely diagnosis, treatment, and survival outcomes. Hormone receptor-positive breast cancer is prevalent in this population, with endocrine blocking therapy (EBT) recommended as a standard treatment. However, Hispanic breast cancer survivors exhibit higher rates of EBT non-adherence, influenced by factors such as side effects, medication access, and patient-provider communication. This study investigates the perceptions of Hispanic breast cancer survivors on EBT use and identifies factors contributing to adherence challenges, aiming to address disparities and improve outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the National Hispanic Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
